|
RU2386638C2
(ru)
*
|
2004-03-31 |
2010-04-20 |
Дженентек, Инк. |
Гуманизированные анти-тфр-бета-антитела
|
|
WO2007076391A1
(en)
*
|
2005-12-23 |
2007-07-05 |
Eli Lilly And Company |
Tgf-beta binding compositions
|
|
US8350006B2
(en)
*
|
2008-10-24 |
2013-01-08 |
Mead Johnson Nutrition Company |
Methods for determining the bioactivity of TGF-β in a composition
|
|
EP2894226B1
(en)
*
|
2009-01-08 |
2021-04-14 |
Bio-Rad Laboratories, Inc. |
Methods and compositions for improving efficiency of nucleic acids amplification reactions
|
|
ES2702049T3
(es)
*
|
2009-04-24 |
2019-02-27 |
Univ Vanderbilt |
Inducción anti-TGF-beta de crecimiento óseo
|
|
EP3954704A1
(en)
|
2011-06-03 |
2022-02-16 |
XOMA Technology Ltd. |
Antibodies specific for tgf-beta
|
|
WO2013134365A1
(en)
|
2012-03-08 |
2013-09-12 |
Ludwig Institute For Cancer Research Ltd |
TGF-β1 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF
|
|
EP2822871A4
(en)
|
2012-03-08 |
2015-12-09 |
Selig Sealing Products Inc |
TANK SEALING ELEMENT WITH A PROTECTED SAFETY COMPONENT AND A REMOVAL BAG
|
|
EA032327B1
(ru)
*
|
2013-03-20 |
2019-05-31 |
Джензим Корпорейшн |
Способы лечения несовершенного остеогенеза
|
|
WO2016024628A1
(ja)
*
|
2014-08-14 |
2016-02-18 |
学校法人東京医科大学 |
樹状細胞の抗癌免疫賦活能の促進方法およびその用途
|
|
CA2973978A1
(en)
|
2015-01-14 |
2016-07-21 |
The Brigham And Women's Hospital, Inc. |
Treatment of cancer with anti-lap monoclonal antibodies
|
|
TWI733661B
(zh)
|
2015-03-04 |
2021-07-21 |
美商健臻公司 |
以高親合性、結合性及特異性結合轉化生長因子－β１的經修飾ＩｇＧ抗體
|
|
TWI726870B
(zh)
|
2015-03-04 |
2021-05-11 |
美商健臻公司 |
具有高親和性、結合性及專一性之結合轉形生長因子-β１的ｓｃＦｖ-Ｆｃ二聚體
|
|
CN116327915A
(zh)
|
2015-04-03 |
2023-06-27 |
佐马技术有限公司 |
使用TGF-β抑制剂和PD-1抑制剂治疗癌症
|
|
WO2016201282A2
(en)
|
2015-06-12 |
2016-12-15 |
Ludwig Institute For Cancer Research Ltd |
TGF-β3 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF
|
|
JP7359547B2
(ja)
|
2016-05-17 |
2023-10-11 |
ジェネンテック， インコーポレイテッド |
免疫療法における診断及び使用のための間質遺伝子シグネチャー
|
|
GB201610044D0
(en)
|
2016-06-08 |
2016-07-20 |
Ucb Biopharma Sprl |
Antibodies
|
|
CN109071656B
(zh)
|
2017-01-05 |
2021-05-18 |
璟尚生物制药公司 |
检查点调节物拮抗剂
|
|
AR110755A1
(es)
*
|
2017-01-20 |
2019-05-02 |
Genzyme Corp |
Anticuerpos dirigidos a hueso
|
|
WO2019090263A1
(en)
|
2017-11-06 |
2019-05-09 |
Genentech, Inc. |
Diagnostic and therapeutic methods for cancer
|
|
EP3813864A4
(en)
|
2018-06-29 |
2022-07-20 |
Gensun Biopharma Inc. |
Antitumor antagonists
|
|
WO2020095113A1
(en)
|
2018-11-05 |
2020-05-14 |
Ludwig Institute For Cancer Research Ltd |
Humanized and variant tgf-beta1 specific antibodies and methods and uses thereof
|
|
WO2020095104A1
(en)
|
2018-11-05 |
2020-05-14 |
Ludwig Institute For Cancer Research Ltd. |
HUMANIZED AND VARIANT TGF-β3 SPECIFIC ANTIBODIES AND METHODS AND USES THEREOF
|
|
WO2020263312A1
(en)
|
2019-06-28 |
2020-12-30 |
Gensun Biopharma, Inc. |
ANTITUMOR ANTAGONIST CONSISTING OF A MUTATED TGFβ1 - RII EXTRACELLULAR DOMAIN AND AN IMMUNOGLOBULIN SCAFFOLD
|
|
CA3152371A1
(en)
|
2019-08-01 |
2021-02-04 |
Vaccinex, Inc. |
Combined inhibition of semaphorin-4d and tgf.beta. and compositions therefor
|
|
CN115243724B
(zh)
|
2020-02-19 |
2025-10-21 |
纳米医疗有限公司 |
可用于治疗癌症的经调配和/或共调配的含有TFGβ拮抗剂前药的脂质体组合物和其方法
|
|
CN113563473A
(zh)
|
2020-04-29 |
2021-10-29 |
三生国健药业（上海）股份有限公司 |
四价双特异性抗体、其制备方法和用途
|
|
US20240002479A1
(en)
*
|
2020-11-23 |
2024-01-04 |
The Regents Of The University Of Michigan |
Single-chain antibody against flavivirus ns1 protein
|
|
WO2022115611A1
(en)
|
2020-11-25 |
2022-06-02 |
Catamaran Bio, Inc. |
Cellular therapeutics engineered with signal modulators and methods of use thereof
|
|
CN112940119B
(zh)
*
|
2021-04-26 |
2022-05-20 |
北京芳渟阳生生物科技有限公司 |
一种单克隆抗体及其与间充质干细胞外泌体的联合应用
|
|
CN115707716A
(zh)
*
|
2021-08-18 |
2023-02-21 |
丹生医药技术(上海)有限公司 |
一种TGF-β/VEGF双功能抗体融合蛋白
|
|
WO2023080900A1
(en)
|
2021-11-05 |
2023-05-11 |
Genentech, Inc. |
Methods and compositions for classifying and treating kidney cancer
|
|
EP4527857A1
(en)
|
2022-05-17 |
2025-03-26 |
Suzhou Transcenta Therapeutics Co., Ltd. |
Bifunctional protein, and preparation thereof and use thereof
|
|
WO2024077166A1
(en)
|
2022-10-05 |
2024-04-11 |
Genentech, Inc. |
Methods and compositions for classifying and treating lung cancer
|
|
EP4599089A1
(en)
|
2022-10-05 |
2025-08-13 |
Genentech, Inc. |
Methods and compositions for classifying and treating bladder cancer
|
|
JP2026504831A
(ja)
*
|
2023-01-09 |
2026-02-10 |
北京拓界生物医薬科技有限公司 |
ＴＧＦβ１結合分子、ＧＡＲＰ－ＴＧＦβ１結合分子及びそれらの医薬的使用
|